Publicaciones en colaboración con investigadores/as de Centro Nacional de Microbiología (52)

2024

  1. Decrease in active hepatitis C infection among people who use drugs in Madrid, Spain, 2017 to 2023: a retrospective study

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 29, Núm. 29

  2. Diagnostic performance of dried blood spot hepatitis C virus core antigen testing for hepatitis C screening: A systematic review and meta-analysis

    Journal of Medical Virology, Vol. 96, Núm. 10

  3. Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study

    Journal of Infection and Public Health, Vol. 17, Núm. 7

  4. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  5. Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain

    JAMA network open, Vol. 7, Núm. 10, pp. e2438657

  6. Recently acquired hepatitis C: Epidemiological characteristics and treatment response in a large cohort of MSM living with HIV in Madrid

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 8, pp. 414-419

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Diagnostic performance of hepatitis C core antigen assay to identify active infections: A systematic review and meta-analysis

    Reviews in Medical Virology, Vol. 33, Núm. 3

  3. Dynamics of cellular senescence markers after HCV elimination spontaneously or by DAAs in people living with HIV

    Biomedicine and Pharmacotherapy, Vol. 162

  4. Evaluation of the Panbio™ COVID-19 IgG rapid test device performance

    Heliyon, Vol. 9, Núm. 12

  5. HCV spontaneous clearers showed low senescence profile in people living with HIV under long ART

    Journal of Medical Virology, Vol. 95, Núm. 7

  6. HCV, HIV AND HBV rapid test diagnosis in non-clinical outreach settings can be as accurate as conventional laboratory tests

    Scientific Reports, Vol. 13, Núm. 1

  7. Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk

    Immunity and Ageing, Vol. 20, Núm. 1

  8. MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

    Journal of Molecular Medicine, Vol. 101, Núm. 11, pp. 1409-1420

  9. Relative telomere length impact on mortality of COVID-19: Sex differences

    Journal of Medical Virology, Vol. 95, Núm. 1

2022

  1. Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-care

    Liver International, Vol. 42, Núm. 2, pp. 309-319

  2. Dynamics of HIV Reservoir and HIV‐1 Viral Splicing in HCV‐Exposed Individuals after Elimination with DAAs or Spontaneous Clearance

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  3. HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization

    Biomedicine and Pharmacotherapy, Vol. 145

  4. Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation

    Frontiers in Immunology, Vol. 13

  5. Misdiagnosis rate among negative COVID-19 patients in real-life with Panbio COVID-19 antigen rapid test during 2021

    Journal of Infection